Henk P. Swart

Colchicine in Patients with Chronic Coronary Disease

Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text

Medicine, Cardiology, Pharmacology +15

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13

Randomized, Double-Blind, Placebo-Controlled, Multicentre Pilot Study on the Effects of Empagliflozin on Clinical Outcomes in Patients with Acute Decompensated Heart Failure (EMPA-RESPONSE-AHF)

Kevin Damman, Joost C. Beusekamp, Eva M. Boorsma et al. · European Journal of Heart Failure · 2020 · 447 citations · Full text

Medicine, Cardiology, Pharmacology +15

Effects of Danicamtiv, a Novel Cardiac Myosin Activator, in Heart Failure with Reduced Ejection Fraction: Experimental Data and Clinical Results from a Phase 2a Trial

Adriaan A. Voors, Jean‐François Tamby, John G.F. Cleland et al. · European Journal of Heart Failure · 2020 · 106 citations · Full text

Medicine, Cardiology, Pharmacology +15